Medical Cannabis Research Act of 2018
This bill amends the Controlled Substances Act to establish a new, separate registration process for manufacturers of cannabis for research.
The Drug Enforcement Administration must assess whether there is an adequate and uninterrupted supply of research cannabis and register additional manufacturers.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.